510(k) K851635
K851635 is an FDA 510(k) premarket notification submitted by Diagnon Corp. for the device "DIAGNON HERPES IMMUNOPEROXIDASE TYPING TEST". The FDA issued a decision of Substantially Equivalent on Oct 10, 1985. The device falls under product code GQL (Antisera, Fluorescent, Herpesvirus Hominis 1,2), a Class II device regulated under 21 CFR 866.3305. Diagnon Corp. has 5 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 10, 1985
- Date Received
- Apr 18, 1985
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antisera, Fluorescent, Herpesvirus Hominis 1,2
- Device Class
- Class II
- Regulation Number
- 866.3305
- Review Panel
- MI
- Submission Type
- 510(k)
Need the full FDA record for Diagnon Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.